Karin J. Beelen
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 3
- Cancer Genomics and Diagnostics 2
- Oncology 5
- HER2/EGFR in Cancer Research 5
- Co-authors
- Sabine Linn (13 shared papers)Hugo M. Horlings (2 shared papers)Michael Hauptmann (3 shared papers)Gordon Brent Mills (1 shared paper)Bryan T. Hennessy (1 shared paper)Rene Bernards (1 shared paper)Mandy Madiredjo (1 shared paper)E. Marielle Hijmans (1 shared paper)
- Journals
- Breast Cancer Research (3 papers)Breast Cancer Research and Treatment (2 papers)Clinical Cancer Research (2 papers)BMC Cancer (2 papers)iScience (1 paper)
- Partner nations
- NetherlandsBelgiumSpain
In The Last Decade
Karin J. Beelen
23 papers receiving 1.9k citations
Karin J. Beelen's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 1.0k
- Cancer Research 332
- Radiology, Nuclear Medicine and Imaging 342
- Genetics 152
- Molecular Biology 896
Countries citing papers authored by Karin J. Beelen
This map shows the geographic impact of Karin J. Beelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin J. Beelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin J. Beelen more than expected).
Fields of papers citing papers by Karin J. Beelen
This network shows the impact of papers produced by Karin J. Beelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin J. Beelen. The network helps show where Karin J. Beelen may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin J. Beelen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer Hit paper breakdown → | 2007 | 1370 |
| 2 | 2019 | 100 | |
| 3 | 2013 | 84 | |
| 4 | 2012 | 64 | |
| 5 | 2014 | 54 | |
| 6 | 2024 | 43 | |
| 7 | 2014 | 42 | |
| 8 | 2014 | 28 | |
| 9 | 2013 | 21 | |
| 10 | 2015 | 21 | |
| 11 | 2018 | 20 | |
| 12 | 2019 | 20 | |
| 13 | 2019 | 17 | |
| 14 | 2022 | 14 | |
| 15 | 2018 | 7 | |
| 16 | 2020 | 7 | |
| 17 | 2015 | 6 | |
| 18 | 2024 | 3 | |
| 19 | 2024 | 2 | |
| 20 | [Confusion and abdominal pain after COVID-19 vaccination]. | 2021 | 1 |
About Karin J. Beelen
Karin J. Beelen is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 1.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), HER2/EGFR in Cancer Research (5 papers), Advanced Breast Cancer Therapies (4 papers), Estrogen and related hormone effects (3 papers), Breast Cancer Treatment Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer-related cognitive impairment studies (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (332 citations), Radiology, Nuclear Medicine and Imaging (342 citations), Genetics (152 citations) and Molecular Biology (896 citations). Karin J. Beelen has collaborated with scholars based in Netherlands, Belgium and Spain. Frequent co-authors include Sabine Linn, Hugo M. Horlings, Michael Hauptmann, Gordon Brent Mills, Bryan T. Hennessy, Rene Bernards, Mandy Madiredjo, E. Marielle Hijmans, Katrien Berns and Katherine Stemke‐Hale. Their work appears in journals such as Breast Cancer Research, Breast Cancer Research and Treatment, Clinical Cancer Research, BMC Cancer and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.